India is an example in front of the world to contribute towards strengthening Points of Entry during a public health emergency
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
The Centre aims at promoting innovation among the scientific community to improve healthcare solutions around the globe
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
The book “Science behind Suryanamaskar” has been compiled by the AIIA’s Department of Swasthavritta and Yoga.
Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age
Subscribe To Our Newsletter & Stay Updated
